SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-08-004608
Filing Date
2008-05-28
Accepted
2008-05-28 06:04:57
Documents
2
Period of Report
2008-05-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 INTROGEN THERAPEUTICS, INC. 8-K a5695417.htm 8-K 14658
2 EXHIBIT 99.1 a5695417ex99_1.htm EX-99.1 22282
  Complete submission text file 0001157523-08-004608.txt   38426
Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Filer) CIK: 0001018710 (see all company filings)

IRS No.: 742704230 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21291 | Film No.: 08862295
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1